Peptilogics Closes $35.4 Million Series B Financing to Further Advance Proprietary Computational Peptide Drug Design and Discovery Platform

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3mEOR60
via IFTTT